Oncology Journal Articles

• Radiomics in Precision Medicine for Lung Cancer Potential uses for radiomics in lung cancer include basic image segmentation, outcome modeling, and even the deciphering of genetic signatures.
  Translational Lung Cancer Research, February 2018
• Local Immunotherapy of Cancer: Innovative Approaches Review the latest early research on intratumoral and intranodal immunotherapies.
  Journal of the National Cancer Institute, February 2018
• Response of High-Grade Gliomas to Checkpoint Inhibitors How should MRI findings be used to assess response of high-grade gliomas to immunotherapy?
  Cancer Control: Journal of the Moffitt Cancer Center, February 2018
• Depth of Response in NSCLC with Targeted or Immunotherapies Greater depth of response may be associated with overall survival and progression-free survival and could be considered as an additional outcome measure for clinical trials.
  Annals of Oncology, February 2018
• Depth of Response in PETHEMA/GEM Myeloma Trials According to this research, minimal residual disease negativity should be considered one of the most relevant clinical endpoints for some populations of patients with MM.
  Journal of Clinical Oncology, February 2018
• Tumor Biomarkers in Lung Cancer for Detection and Treatment Review the roles of circulating tumor cells, circulating tumor DNA, microRNA and other biomarkers for lung cancer management.
  Translational Lung Cancer Research, February 2018
• Representation of Minorities and Women in Oncology Trials Do clinical trials in oncology adequately represent the US population with cancer?
  Journal of Oncology Practice, February 2018
• Supplements and Chemotherapy-Induced Peripheral Neuropathy Do multivitamins mitigate development of chemotherapy-induced peripheral neuropathy?
  Journal of the National Cancer Institute, February 2018
• Imaging Management of Breast Density Review evidence around tomosynthesis, ultrasonography, MRI, and molecular-based imaging as adjuvants to mammography in patients with breast density.
  Cancer Control: Journal of the Moffitt Cancer Center, February 2018
• Predictors of Paclitaxel Neurotoxicity A new study finds discordance between patient- and clinician-reported neurotoxicity associated with paclitaxel.
  Annals of Oncology, February 2018
• Predictive and Prognostic Marker Assessments in Lung Cancer Advances in personalized medicine and histologic classification and staging are furthering lung cancer management.
  Translational Lung Cancer Research, January 2018
• Rise of Radiomics and Implications for Oncologic Management Advancements in modern medical imaging are contributing to "radiomics," a new avenue for personalized care in oncology.
  Journal of the National Cancer Institute, January 2018
• Association Between Air Pollution and Mammographic Breast Density Does exposure to ozone and particulate matter in ambient air affect breast density?
  Breast Cancer Research, January 2018
• Surgical Treatment for Leptomeningeal Disease Review use and associated risks of Ommaya reservoirs and ventriculoperitoneal shunts for leptomeningeal disease.
  Cancer Control: Journal of the Moffitt Cancer Center, January 2018
• Interpreting Subgroups and the STAMPEDE Trial Subgroup analyses of the STAMPEDE trial for prostate cancer may have been subject to over- and under-interpretation. What are the potential implications of such misrepresentations?
  Annals of Oncology, January 2018
• Reproductive Profiles and Risk of Breast Cancer Subtypes Is parity associated with risk of triple-negative breast cancer?
  Breast Cancer Research, January 2018
• Update on Large Cell Neuroendocrine Carcinoma Review molecular features and treatment options for large cell neuroendocrine carcinoma of the lung.
  Translational Lung Cancer Research, January 2018
• Incidence of Lung Adenocarcinoma in Never Smokers Despite a decrease in exposure to secondhand smoke, never smokers continue to be at risk for lung cancer.
  Journal of the National Cancer Institute, January 2018
• Estrogen Axis Regulation of ER-Positive Breast Cancer Cells Strategies to minimize endocrine resistance may involve estrogen signaling networks within the bone microenvironment.
  Breast Cancer Research, January 2018
• Experimental Treatments for Leptomeningeal Metastases Novel agents that penetrate the blood-brain barrier offer new hope for effective management of leptomeningeal metastases.
  Cancer Control: Journal of the Moffitt Cancer Center, January 2018